Work

3TR Project: Crossing disease borders to reshape European research

Year: 2026

Type: article

Abstract: 3TR Project: Crossing disease borders to reshape European research By utilising advanced technologies, the 3TR project aims to transform the understanding and treatment of immune-mediated diseases, with its core principles in precision medicine. Principal investigator, Marta E. Alarcon-Riquelme, explains. At a time when chronic diseases place growing pressure on patients and health systems alike, one European research consortium is rewriting how science is done. The 3TR project - short for Taxonomy, Treatment, Targets, and Remission – is a groundbreaking effort to understand the shared mechanisms driving immune-mediated diseases and to pave the way for truly personalised medicine across Europe.

Source: Open Access Government

DOI: 10.56367/oag-049-12296

Author: Marta E. Alarcon-Riquelme

Institution: Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7125227097